UNSPSC 85711422: Fusion of left acromioclavicular joint with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to fusion of left acromioclavicular joint with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RGH3KZ

UNSPSC 85711422 Fusion of left acromioclavicular joint with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent state and local procurement activity. The code's clinical taxonomy—describing a specific orthopedic surgical procedure—does not align with the actual purchasing patterns reflected in recent state and local contract opportunities posted under this classification.

The six most recent opportunities tagged to this code span independent medical evaluation services for pension disability determinations, surgical benefit carve-outs for employee health plans, occupational medical surveillance for state ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management for county employees, and temporary health professional staffing pools. None of these solicitations involve fusion procedures, implants, tissue substitutes, or the operative services the code nominally describes. The issuing bodies include the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation, Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California). The geographic spread covers Arizona, California, Florida, Texas, and Washington, with no concentration in any single region. This code appears to be a misclassification artifact in state and local procurement systems; vendors pursuing orthopedic implant, tissue substitute, or operative service contracts should monitor more specific UNSPSC families focused on medical devices, implants, and surgical services rather than rely on opportunities appearing under this code.